Porcine Vaccine Market Size to Grow by USD 794.67 million | Bimeda Inc. and Bioveta AS Among Key Vendors| Technavio

NEW YORK, April 13, 2022 /PRNewswire/ — According to the report “Porcine Vaccine Market by Product and Geography – Forecast and Analysis 2022-2026“, the market will witness a YOY growth of 6.2% in 2022 and a CAGR of 7.01% during the forecast period. The report is segmented by product (intravenous, intramuscular, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)).

For more insights related to market dynamics, Read our FREE Sample Report

Vendor Insights 

The porcine vaccine market is concentrated, and the vendors are deploying organic and inorganic growth strategies to compete in the market. The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

• Bimeda Inc.
• Bioveta AS
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Elanco Animal Health Inc.
• FATRO SpA
• Formosa Biomedical Inc.
• LABORATORIOS HIPRA SA
• Merck and Co. Inc.
• Phibro Animal Health Corp.
• Veterinary Provisions Inc.
• Vetoquinol SA
• Virbac Group
• Zoetis Inc.

Find additional highlights on the growth strategies adopted by vendors and their product offerings. Read Free Sample Report. 

Geographical Market Analysis 

North America will provide maximum growth opportunities during the forecast period. According to our research, the region will contribute to 42% of the global market during the forecast period. The US and Canada are the two major markets in North America. The rising animal healthcare expenditure will facilitate the porcine vaccine market growth in North America over the forecast period. 

Know more about this market’s geographical distribution along with a detailed analysis of the top regions. View our Report Snapshot

Key Segment Analysis

The porcine vaccine market share growth by the intravenous segment will be significant during the forecast period. Proper injection techniques should be followed in order to minimize pain at the site of injection and avoid the accumulation of illegal residues in pigs. Intravenous (IV) and intramuscular (IM), among others, are the routes of administration for porcine vaccines. Vendors in the market offer inactivated vaccines, live attenuated vaccines, toxoid vaccines, and recombinant vaccines, which can be administered intravenously. Thus, the availability of a wide range of porcine vaccines that can be administered intravenously will drive the growth of the global porcine vaccine during the forecast period.

View FREE Sample: to know additional highlights and key points on various market segments and their impact in coming years. 

Key Market Drivers & Challenges: 

The increasing prevalence of porcine diseases is driving the porcine vaccine market growth. Porcine vaccines can be used in the treatment and management of various epidemic porcine diseases such as PRRS, porcine circovirus-associated disease (PCVAD), and other target diseases. The rising prevalence of such porcine diseases will lead to an increase in demand for inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, and other porcine vaccines during the forecast period. This will drive the porcine vaccine market growth during the forecast period.

The lack of trained veterinary doctors is challenging the porcine vaccine market growth. The lack of highly skilled professionals negatively impacts the adoption and use of porcine vaccines. Moreover, the decrease in the number of educational programs on epidemic porcine diseases that are offered to veterinary students, the presence of inadequate facilities in veterinary centers, and the lack of veterinary hospitals and clinics in emerging economies lead to a lack of awareness about porcine diseases and vaccines. These factors will have a negative impact on the growth of the global porcine vaccine market during the forecast period.

Download free sample for highlights on market Drivers & Challenges impacting the market. 

Customize Your Report 

Don’t miss out on the opportunity to speak to our analyst and know more insights about this market report. Our analysts can also help you customize this report according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.  

We offer USD 1,000 worth of FREE customization at the time of purchase. Speak to our Analyst now! 

Related Reports: 

Hepatitis B Therapeutics Market by Application and Geography – Forecast and Analysis 2022-2026

Smart Pills Drug Delivery Market by Application and Geography – Forecast and Analysis 2022-2026

Table of Contents:

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis – Comparison between2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition – Five forces 2021 and 2026

5 Market Segmentation by Product

• 5.1 Market segments
• Exhibit 24: Chart on Product – Market share 2021-2026 (%)
• Exhibit 25: Data Table on Product – Market share 2021-2026 (%)

• 5.2 Comparison by Product
• Exhibit 26: Chart on Comparison by Product
• Exhibit 27: Data Table on Comparison by Product

• 5.3 Intravenous – Market size and forecast 2021-2026
• Exhibit 28: Chart on Intravenous – Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Intravenous – Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Intravenous – Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Intravenous – Year-over-year growth 2021-2026 (%)

• 5.4 Intramuscular – Market size and forecast 2021-2026
• Exhibit 32: Chart on Intramuscular – Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Intramuscular – Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Intramuscular – Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Intramuscular – Year-over-year growth 2021-2026 (%)

• 5.5 Others – Market size and forecast 2021-2026
• Exhibit 36: Chart on Others – Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Others – Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Others – Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Others – Year-over-year growth 2021-2026 (%)

• 5.6 Market opportunity by Product
• Exhibit 40: Market opportunity by Product ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 42: Chart on Market share by geography 2021-2026 (%)
• Exhibit 43: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison

• 7.3 North America – Market size and forecast 2021-2026
• Exhibit 46: Chart on North America – Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America – Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America – Year-over-year growth 2021-2026 (%)

• 7.4 Europe – Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe – Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe – Year-over-year growth 2021-2026 (%)

• 7.5 Asia – Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia – Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia – Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)

• 7.7 US – Market size and forecast 2021-2026
• Exhibit 62: Chart on US – Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US – Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US – Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US – Year-over-year growth 2021-2026 (%)

• 7.8 Germany – Market size and forecast 2021-2026
• Exhibit 66: Chart on Germany – Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Germany – Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Germany – Year-over-year growth 2021-2026 (%)

• 7.9 UK – Market size and forecast 2021-2026
• Exhibit 70: Chart on UK – Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on UK – Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on UK – Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on UK – Year-over-year growth 2021-2026 (%)

• 7.10 China – Market size and forecast 2021-2026
• Exhibit 74: Chart on China – Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on China – Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on China – Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on China – Year-over-year growth 2021-2026 (%)

• 7.11 Canada – Market size and forecast 2021-2026
• Exhibit 78: Chart on Canada – Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on Canada – Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on Canada – Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on Canada – Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 85: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 87: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 88: Matrix on vendor position and classification

• 10.3 Bioveta AS
• Exhibit 89: Bioveta AS – Overview
• Exhibit 90: Bioveta AS – Product / Service
• Exhibit 91: Bioveta AS – Key offerings

• 10.4 Boehringer Ingelheim International GmbH
• Exhibit 92: Boehringer Ingelheim International GmbH – Overview
• Exhibit 93: Boehringer Ingelheim International GmbH – Business segments
• Exhibit 94: Boehringer Ingelheim International GmbH – Key news
• Exhibit 95: Boehringer Ingelheim International GmbH – Key offerings
• Exhibit 96: Boehringer Ingelheim International GmbH – Segment focus

• 10.5 Ceva Sante Animale
• Exhibit 97: Ceva Sante Animale – Overview
• Exhibit 98: Ceva Sante Animale – Product / Service
• Exhibit 99: Ceva Sante Animale – Key offerings

• 10.6 FATRO SpA
• Exhibit 100: FATRO SpA – Overview
• Exhibit 101: FATRO SpA – Product / Service
• Exhibit 102: FATRO SpA – Key offerings

• 10.7 Formosa Biomedical Inc.
• Exhibit 103: Formosa Biomedical Inc. – Overview
• Exhibit 104: Formosa Biomedical Inc. – Product / Service
• Exhibit 105: Formosa Biomedical Inc. – Key offerings

• 10.8 LABORATORIOS HIPRA SA
• Exhibit 106: LABORATORIOS HIPRA SA – Overview
• Exhibit 107: LABORATORIOS HIPRA SA – Product / Service
• Exhibit 108: LABORATORIOS HIPRA SA – Key offerings

• 10.9 Merck and Co. Inc.
• Exhibit 109: Merck and Co. Inc. – Overview
• Exhibit 110: Merck and Co. Inc. – Business segments
• Exhibit 111: Merck and Co. Inc. – Key news
• Exhibit 112: Merck and Co. Inc. – Key offerings
• Exhibit 113: Merck and Co. Inc. – Segment focus

• 10.10 Phibro Animal Health Corp.
• Exhibit 114: Phibro Animal Health Corp. – Overview
• Exhibit 115: Phibro Animal Health Corp. – Business segments
• Exhibit 116: Phibro Animal Health Corp. – Key offerings
• Exhibit 117: Phibro Animal Health Corp. – Segment focus

• 10.11 Virbac Group
• Exhibit 118: Virbac Group – Overview
• Exhibit 119: Virbac Group – Business segments
• Exhibit 120: Virbac Group – Key news
• Exhibit 121: Virbac Group – Key offerings
• Exhibit 122: Virbac Group – Segment focus

• 10.12 Zoetis Inc.
• Exhibit 123: Zoetis Inc. – Overview
• Exhibit 124: Zoetis Inc. – Business segments
• Exhibit 125: Zoetis Inc. – Key news
• Exhibit 126: Zoetis Inc. – Key offerings
• Exhibit 127: Zoetis Inc. – Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 128: Inclusions checklist
• Exhibit 129: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 130: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 131: Research methodology
• Exhibit 132: Validation techniques employed for market sizing
• Exhibit 133: Information sources

• 11.5 List of abbreviations
• Exhibit 134: List of abbreviations

About Us: 

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. 

Contact 
Technavio Research 
Jesse Maida 
Media & Marketing Executive 
US: +1 844 364 1100 
UK: +44 203 893 3200 
Email: [email protected] 
Website: www.technavio.com/ 

View original content to download multimedia:https://www.prnewswire.com/news-releases/porcine-vaccine-market-size-to-grow-by-usd-794-67-million–bimeda-inc-and-bioveta-as-among-key-vendors-technavio-301523725.html

SOURCE Technavio

PR Newswire Science News